eISSN: 2081-2841
ISSN: 1689-832X
Journal of Contemporary Brachytherapy
Current Issue Archive Supplements Articles in Press Journal Information Aims and Scope Editorial Office Editorial Board Register as Author Register as Reviewer Instructions for Authors Abstracting and indexing Subscription Advertising Information Links
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank

4/2018
vol. 10
 
Share:
Share:
abstract:
Original paper

Radiobiological doses, tumor, and treatment features influence on local control, enucleation rates, and survival after epiescleral brachytherapy. A 20-year retrospective analysis from a single-institution: part I

David Miguel
,
Jesus María Frutos-Baraja
,
Francisco López-Lara
,
María Antonia Saornil
,
Ciro García-Álvarez
,
Pilar Alonso
,
Patricia Diezhandino

J Contemp Brachytherapy 2018; 10, 4: 337–346
Online publish date: 2018/08/31
View full text Get citation
 
Purpose
To assess influence of the radiobiological doses, tumor, and treatment features on local control, enucleation rates, overall and disease-specific survival rates after brachytherapy for posterior uveal melanoma.

Material and methods
Local control, enucleation, overall and disease-specific survival rates were evaluated on the base of 243 patients from 1996 through 2016, using plaques loaded with iodine sources. Clinical and radiotherapy data were extracted from a dedicated prospective database. Biologically effective dose (BED) was included in survival analysis using Kaplan-Meier and Cox regressions. The 3-, 5-, 10-, and 15-year relative survival rates were estimated, and univariate/multivariate regression models were constructed for predictive factors of each item. Hazard ratio (HR) and confidence interval at 95% (CI) were determined.

Results
The median follow-up was 73.9 months (range, 3-202 months). Cumulative probabilities of survival by Kaplan-Meier analysis at 3, 5, 10 and 15 years were respectively: 96%, 94%, 93%, and 87%, for local control; 93%, 88%, 81%, and 73% for globe preservation; 98%, 93%, 84%, and 73% for overall survival, and 98%, 96%, 92%, and 87% for disease-specific survival. By multivariate analysis, we concluded variables as significant: for local control failure – the longest basal diameter and the juxtapapillary location; for globe preservation failure – the longest basal dimension, the mushroom shape, the location in ciliary body, and the dose to the foveola; for disease-specific survival – the longest basal dimension. Some radiobiological doses were significant in univariate models but not in multivariate ones for the items studied.

Conclusions
The results show as predictive factors of local control, enucleation, and disease-specific survival rates those related with the features of the tumor, specifically the longest basal dimension. There is no clear relation between radiobiological doses or treatment parameters in patients after brachytherapy.

keywords:

brachytherapy, disease-specific survival, enucleation, local control, radiobiological doses, uveal melanoma

 
Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.